Reaction

Arteriospasm Coronary reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,895 reports · 99 co-occurring drugs

As of the last recalculation, Arteriospasm Coronary appears in 3,895 FAERS reports alongside 99 co-occurring drug terms. The strongest observed disproportionality signal is OXALIPLATIN (PRR 50.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Oxaliplatin	591	50.0	50.4
Fluorouracil Cream, 0.5%	549	44.6	44.9
Fluorouracil	550	44.1	44.4
Capecitabine	585	40.0	40.3
Sevoflurane	47	30.6	30.7
Sumatriptan Succinate	117	25.5	25.6
Rocuronium Bromide	50	23.0	23.1
Propofol	150	22.8	22.9
Sumatriptan	142	20.6	20.7
Leucovorin Calcium	72	20.5	20.6
Atropine Sulfate	38	19.0	19.0
Isosorbide Mononitrate	70	18.3	18.4
Norepinephrine Bitartrate	48	18.0	18.1
Misoprostol	31	17.1	17.2
Norepinephrine	34	17.1	17.2
Atropine	26	16.9	16.9
Adrenalinum	115	15.2	15.3
Daptomycin	24	14.0	14.0
Nitroglycerin	131	13.5	13.5
Isosorbide Dinitrate	48	13.3	13.3
Meperidine Hydrochloride	22	12.8	12.9
Epinephrine	130	10.9	11.0
Rizatriptan Benzoate	20	10.6	10.6
Desloratadine	17	8.5	8.5
Bupivacaine	14	8.0	8.0
Midazolam Hydrochloride	36	7.2	7.2
Ranolazine	14	7.2	7.2
Cefazolin Sodium	16	7.1	7.1
Cefazolin	12	7.0	7.1
Piperacillin Sodium,Tazobactam Sodium	34	6.9	6.9
Midazolam	32	6.8	6.8
Nifedipine	59	6.8	6.8
Aprepitant	23	6.7	6.7
Cisplatin	92	6.4	6.4
Ceftriaxone Sodium	45	6.3	6.3
Loperamide Hydrochloride Oral	12	6.3	6.3
Piperacillin And Tazobactam	15	6.3	6.3
Loperamide Hcl	14	5.8	5.8
Bevacizumab	128	5.7	5.7
Candesartan	37	5.6	5.6
Fentanyl Citrate	18	5.4	5.4
Methylphenidate Hydrochloride	59	5.4	5.4
Lapatinib	15	5.2	5.2
Cefuroxime	11	5.2	5.2
Fentanyl	93	5.1	5.1
Granisetron Hydrochloride	10	5.1	5.1
Granisetron	10	5.1	5.1
Losartan Potassium And Hydrochlorothiazide	11	5.1	5.1
Irinotecan Hydrochloride	12	5.0	5.0
Metronidazole Topical	44	5.0	5.0
Ceftriaxone	30	4.9	4.9
Bosutinib	8	4.8	4.8
Temozolomide	18	4.6	4.6
Gemcitabine Hydrochloride	45	4.6	4.6
Lidocaine Hydrochloride And Epinephrine Bitartrate	45	4.5	4.6
Diphenhydramine	53	4.5	4.5
Piperacillin Sodium And Tazobactam Sodium	16	4.4	4.4
Gemcitabine	32	4.4	4.4
Salmeterol Xinafoate	7	4.3	4.3
Clopidogrel Bisulfate	81	4.3	4.3
Metronidazole	50	4.2	4.2
Ticagrelor	25	4.2	4.2
Nevirapine	7	4.2	4.2
Ondansetron	83	4.1	4.1
Ondansetron Tablets	83	4.1	4.1
Heparin Sodium	10	3.9	3.9
Amphetamine	6	3.9	3.9
Iohexol	6	3.9	3.9
Ondansetron Hydrochloride	86	3.8	3.8
Methylphenidate	20	3.7	3.7
Colchicine	18	3.7	3.7
Nilotinib	20	3.6	3.6
Clopidogrel	127	3.5	3.5
Trastuzumab	43	3.4	3.4
Iron Sucrose	6	3.4	3.4
Eplerenone	8	3.3	3.3
Imatinib	11	3.3	3.3
Metoclopramide	33	3.2	3.2
Benralizumab	12	3.2	3.2
Lisinopril And Hydrochlorothiazide	6	3.1	3.1
Docetaxel Anhydrous	38	3.0	3.0
Docetaxel	38	3.0	3.0
Cetuximab	17	2.9	2.9
Paclitaxel (Aibumin-Bound)	43	2.8	2.8
Pemetrexed Disodium	20	2.8	2.8
Prochlorperazine	14	2.7	2.7
Panitumumab	7	2.4	2.4
Erenumab-Aooe	24	2.3	2.3
Paclitaxel	43	2.3	2.3
Prasugrel Hydrochloride	4	2.1	2.1
Daratumumab	15	2.0	2.0
Pseudoephedrine Hcl	4	1.9	1.9
Alirocumab	9	1.9	1.9
Ado-Trastuzumab Emtansine	3	1.9	1.9
Dasatinib	12	1.7	1.7
Erlotinib Hydrochloride	4	1.7	1.7
Durvalumab	6	1.6	1.6
Pseudoephedrine Hydrochloride	3	1.6	1.6
Trifluridine And Tipiracil	3	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.